Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogenic Bone Marrow MSCs for Steroid-refractory GVHD
NCT02824653Phase 2Completed
- Sponsor
- National Institute of Blood and Marrow Transplant
- Start
- Jan 2015
- Primary completion
- Jul 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in graft-versus-host disease (GVHD), sponsored by National Institute of Blood and Marrow Transplant. Started Jan 2015; status: completed.
02
Drugs
mesenchymal stem cells
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT02824653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02824653.